{"disease":{"id":"hfs","name":"hfs"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06856590","title":"ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Gazi University","has_results":false},{"nct_id":"NCT05327751","title":"Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":44,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT04242927","title":"A Study to Investigate Nicotinic Acid on VEGFR Inhibitor-Associated Hand-Foot Skin Reactions","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":36,"lead_sponsor_name":"First People's Hospital of Hangzhou","has_results":false},{"nct_id":"NCT04071756","title":"Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}